F. Bach

A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma

Manfred Westphal, Oliver Heese, Joachim P. Steinbach et al. · European Journal of Cancer · 2015 · 197 citations

Neuro-oncology, Medicine, Immunology +9

Experimental Chemotherapy of Tuberculosis. II. The Synthesis of Pyrazinamides and Related Compounds¹

Sidney R. Kushner, H. Dalalian, Jose Luis Rey Sanjurjo et al. · Journal of the American Chemical Society · 1952 · 145 citations

Medicinal Chemistry, Experimental Chemotherapy, Pharmaceutical Science +14

Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood

Maura Massimino, Veronica Biassoni, Rosalba Miceli et al. · Journal of Neuro-Oncology · 2014 · 98 citations

Radiation Oncology, Pediatric Brain Tumors, Engineering +10

Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial

Maria Teresa Solomón, Julio César Selva, Javier Figueredo et al. · BMC Cancer · 2013 · 78 citations · Full text

Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

Dirk Strumberg, Beate Schultheis, M. E. Scheulen et al. · Investigational New Drugs · 2010 · 66 citations

Pancreatic Cancer, Gastrointestinal Oncology, Medicine +8